Search

Your search keyword '"van de A, Marieke"' showing total 434 results

Search Constraints

Start Over You searched for: Author "van de A, Marieke" Remove constraint Author: "van de A, Marieke"
434 results on '"van de A, Marieke"'

Search Results

1. ADARp150 counteracts whole genome duplication.

11. Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumors

13. Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

14. Extensive preclinical validation of combined RMC-4550 and LY3214996 supports clinical investigation for KRAS mutant pancreatic cancer

15. Genomic and dietary discontinuities during the Mesolithic and Neolithic in Sicily

16. E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer

17. Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer

18. MYC promotes immune-suppression in triple-negative breast cancer via inhibition of interferon signaling

20. Yield and growth duration of Maroon rice landraces measured in traditional settings

21. The impact of an additional copy of chromosome 21 in B-cell precursor acute lymphoblastic leukemia

23. Using Y-chromosome capture enrichment to resolve haplogroup H2 shows new evidence for a two-path Neolithic expansion to Western Europe

25. Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

28. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity

29. MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer

30. Remodelling surgery with 3D printed patient specific surgical guides in patients with chronic diffuse sclerosing osteomyelitis/tendoperiostitis of the mandible, a case series.

33. In situ CRISPR‐Cas9 base editing for the development of genetically engineered mouse models of breast cancer

35. Supplementary Data from A Microfluidic Cancer-on-Chip Platform Predicts Drug Response Using Organotypic Tumor Slice Culture

36. Data from A Microfluidic Cancer-on-Chip Platform Predicts Drug Response Using Organotypic Tumor Slice Culture

37. Data from Loss of the Volume-regulated Anion Channel Components LRRC8A and LRRC8D Limits Platinum Drug Efficacy

38. Figure FS1 from Loss of the Volume-regulated Anion Channel Components LRRC8A and LRRC8D Limits Platinum Drug Efficacy

39. Table TS1 from Loss of the Volume-regulated Anion Channel Components LRRC8A and LRRC8D Limits Platinum Drug Efficacy

40. Data from E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer

44. Supplementary Video S1 from E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer

50. Supplementary Information from E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer

Catalog

Books, media, physical & digital resources